TITLE

2009 - Review: Nicotine gum and varenicline, but not behavioral interventions, reduce relapse in persons who have stopped smoking

AUTHOR(S)
Bentz, Charles J.
PUB. DATE
July 2009
SOURCE
ACP Journal Club;7/21/2009, Vol. 151 Issue 1, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on review of studies on interventions which prevent relapse in persons who stop smoking. The review evaluated behavioral and pharmacologic interventions for relapse prevention (RP) in persons who had stopped smoking on their own or with treatment and those who had enforced abstinence. It concluded that varenicline and nicotine gum reduce relapse in persons who have stopped smoking; behavioral interventions do not reduce risk for relapse.
ACCESSION #
43797545

 

Related Articles

  • Maine's Tobacco Medication Program: Compliance, patterns of use, and satisfaction among smokers. Tworek, Cindy; Haskins, Amy; Susan Woods // Nicotine & Tobacco Research;Jul2009, Vol. 11 Issue 7, p904 

    Introduction:: In 2002, Maine's Tobacco HelpLine began offering free nicotine replacement therapy (NRT), including patch and/or gum, to uninsured adult smokers without NRT benefits. This study assessed compliance, NRT use patterns, and satisfaction among smokers calling the HelpLine and using...

  • Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy. Biazzo, Laura L.; Froshaug, Desireé B.; Harwell, Todd S.; Beck, Heather N.; Haugland, Cynthia; Campbell, Stacy L.; Helgerson, Steven D. // Nicotine & Tobacco Research;Jun2010, Vol. 12 Issue 6, p567 

    Introduction:: Telephone counseling through quitlines combined with cessation medication is an effective strategy to support tobacco cessation. This study assessed the characteristics of quitline enrollees selecting varenicline (Chantix) compared with nicotine replacement therapy (NRT)...

  • Over‐the‐counter availability of nicotine replacement therapy and smoking cessation. Hyland, Andrew; Rezaishiraz, Hamed; Giovino, Gary; Bauer, Joseph E.; Cummings, K. Michael // Nicotine & Tobacco Research;Aug2005, Vol. 7 Issue 4, p547 

    In 1996, the FDA approved over‐the‐counter (OTC) availability of nicotine gum and two brands of nicotine skin patches. Little is known about how this reclassification has influenced the effectiveness and use of nicotine replacement therapy (NRT) and whether it has been a public...

  • Immediate hedonic response to smoking lapses: relationship to smoking relapse, and effects of nicotine replacement therapy. Shiffman, Saul; Ferguson, Stuart G.; Gwaltney, Chad J. // Psychopharmacology;Feb2006, Vol. 184 Issue 3/4, p608 

    The article discusses research on the relation between hedonic response to smoking lapses and smoking relapse. It evaluates the effects of nicotine replacement therapy on the hedonic effect of initial lapses among smokers randomized to high-dose nicotine patch or placebo. It provides information...

  • Do former smokers respond to nicotine differently from never smokers? A pilot study. Hughes, John R.; Rose, Gail L.; Callas, Peter W. // Nicotine & Tobacco Research;Aug2000, Vol. 2 Issue 3, p255 

    Nine former, 11 never, and 10 current smokers abstained from smoking for 16h on each of 4 days. On each of 3 days, participants received three doses per day of 0-, 2-, or 4-mg nicotine gum in a randomized, double-blind, crossover design. To examine subjective effects, participants completed the...

  • Efficacy of over-the-counter nicotine patch. Shiffman, Saul; Gorsline, Jane; Gorodetzky, Charles W. // Nicotine & Tobacco Research;Nov2002, Vol. 4 Issue 4, p477 

    This study aimed to assess the efficacy of the nicotine patch for smoking cessation, under simulated conditions of over-the-counter sale, absent any direct instruction or behavioral treatment. In a randomized, double-blind, placebo-controlled, multicenter study, 567 smokers were randomized to an...

  • Interventions for treatment-resistant smokers. Fagerström, Karl Olov // Nicotine & Tobacco Research;Sep1999 Supplement, Vol. 1, pS201 

    We can understand resistance to treatment in smokers in two ways. First, when there is no awareness that smoking can be responsible for a physical disease, e.g., chronic obstructive lung disease or a dependence disorder. Second, when smokers actually seek treatment but fail to respond...

  • Recall and response of smokers and recent quitters to the Australian National Tobacco Campaign. Wakefield, M.; Freeman, J.; Donovan, R. // Tobacco Control;Sep2003 Supplement 2, Vol. 12, pii15 

    Objective: To track national population indices of recall and response among smokers and recent quitters to an ongoing national televised anti-smoking campaign in Australia. Method: National cross sectional population telephone surveys of adults. Main outcome measures: Unprompted recall of...

  • Nicotine and nonnicotine factors in cigarette addiction. Rose, Jed E. // Psychopharmacology;Feb2006, Vol. 184 Issue 3/4, p274 

    The article discusses research on the nicotine and nonnicotine factors in cigarette addiction. It examines the problem with the nicotine replacement therapy. It cites the nonnicotine components of smoking. It provides information on the methods and materials used in the study. It also discusses...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics